CNBX Pharmaceuticals is a publicly traded company (CNBX: OTCQB) and developer of the world’s first cannabinoid-based antitumor drug candidate for the treatment of colorectal cancer based on the company's novel and proprietary formulation CNBX™️ RCC-33.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 3 Bethesda Metro Centre, Bethesda,maryland 20814,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- cannabics.com
- Keywords
- Science, biotechnology, oncology, cancer, antitumor, colorectal cancer, breast cancer, prostate cancer, data, cancerdata, cannabinoid.
- HQ
- Bethesda, Maryland
Cnbx Pharmaceuticals Questions
Cnbx Pharmaceuticals's website is cannabics.com
Cnbx Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/cnbx
Cnbx Pharmaceuticals has
7 employees.
View email and phone details for 7
employees at Cnbx Pharmaceuticals.
Cnbx Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Cnbx Pharmaceuticals's top competitors are
Nexus Pharmaceuticals,
Lexicon Pharmaceuticals, Inc.,
Corbus Pharmaceuticals,
Chemomab Therapeutics,
Zydus Pharmaceuticals (Usa) Inc.,
Infinity Pharmaceuticals,
Camber Pharmaceuticals Inc,
Cytoreason,
Converge Bio,
Adamas Pharmaceuticals, Inc..
Cnbx Pharmaceuticals's categories are Pharmaceutical Manufacturing
Cnbx Pharmaceuticals's founding year is 2012
